Live Breaking News & Updates on Director Randal

Stay updated with breaking news from Director randal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BridgeBio Pharma (NASDAQ:BBIO) Issues Earnings Results

BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) issued its earnings results on Thursday. The company reported ($0.96) EPS for the quarter, missing analysts’ consensus estimates of ($0.87) by ($0.09), Briefing.com reports. The company had revenue of $1.74 million for the quarter, compared to the consensus estimate of $4.78 million. The firm’s revenue for the quarter […] ....

Frank Mccormick , Randalw Scott , Bridgebio Pharma , Bio Pharma , Cantor Fitzgerald , Topco Ltd , Bridgebio Pharma Company Profile , Wells Fargo Company , Ameritas Investment Partners Inc , Securities Exchange Commission , Bridgebio Pharma Inc , Get Free Report , Wells Fargo , Director Randal , Exchange Commission , Director Frank Mccormick , Investment Partners , Bridgebio Pharma Daily , Nasdaq Bbio ,

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Shares Acquired by Covestor Ltd

Covestor Ltd raised its holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 131.5% in the third quarter, Holdings Channel.com reports. The fund owned 9,587 shares of the company’s stock after acquiring an additional 5,446 shares during the period. Covestor Ltd’s holdings in BridgeBio Pharma were worth $252,000 at the end of the most […] ....

Bio Pharma , Randalw Scott , Hannah Valantine , Bridgebio Pharma Inc , Bridgebio Pharma Company Profile , Cantor Fitzgerald , Covestor Ltd Bio Pharma , Envestnet Asset Management Inc , Securities Exchange Commission , Wells Fargo Company , Covestor Ltd , Holdings Channel , Northern Trust Corp , Algert Global , Healthcare Of Ontario Pension Plan Trust Fund , Bio Pharma Inc , Hermes Inc , Bridgebio Pharma , Free Report , Trust Corp , Ontario Pension Plan Trust Fund , Envestnet Asset Management , Asset Management , Director Randal , Director Hannah Valantine , Exchange Commission ,

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Consensus Rating of "Moderate Buy" by Brokerages

BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twelve analysts that are currently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average twelve-month target […] ....

Bridgebio Pharma , Randalw Scott , Frank Mccormick , Bio Pharma , Cantor Fitzgerald , Securities Exchange Commission , Moody Aldrich Partners , Emerald Mutual Fund Advisers , Wells Fargo Company , Emerald Advisers , Bridgebio Pharma Inc , Campbell Co Investment Adviser , Bridgebio Pharma Company Profile , Get Free Report , Marketbeat Ratings , Director Frank Mccormick , Exchange Commission , Director Randal , Aldrich Partners , Mutual Fund Advisers Trust , Get Free , Bridgebio Pharma Daily , Nasdaq Bbio ,

StockNews.com Upgrades Precigen (NASDAQ:PGEN) to "Sell"

Precigen (NASDAQ:PGEN – Get Free Report) was upgraded by research analysts at StockNews.com to a “sell” rating in a research note issued on Tuesday. Precigen Stock Performance NASDAQ PGEN opened at $1.38 on Tuesday. The company’s fifty day moving average is $1.30 and its two-hundred day moving average is $1.32. Precigen has a 52-week low […] ....

United States , Randalj Kirk , Principal Financial Group Inc , Precigen Inc , Sg Americas Securities , Magnolia Capital Advisors , Sanders Morris Harris , Allspring Global Investments Holdings , Precigen Company Profile , Securities Exchange Commission , Get Free Report , Director Randal , Exchange Commission , Morris Harris , Global Investments Holdings , Financial Group , Capital Advisors , Precigen Daily , Nasdaq Pgen , Stocknews Com ,